Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)

NCT02049320 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2017-02-01

No results posted yet for this study

Summary

This is a descriptive retrospective study designed to measure the efficacy of remifentanil sedation and the ability to perform frequent neurological examinations of patients with traumatic brain injuries.

Conditions

Interventions

DRUG

Remifentanil

Sponsors & Collaborators

  • Joseph D. Tobias

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02049320 on ClinicalTrials.gov